Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pfützner Science & Health Institute (PSHI) is a specialized clinical research organization and medical institute located in Mainz, Germany, focusing on diabetes and metabolic disorders. The institute provides comprehensive clinical trial services, ranging from Phase I to Phase IV, with a particular emphasis on medical devices and pharmaceutical interventions. PSHI is internationally recognized for its expertise in glucose clamp studies, insulin therapy optimization, and the evaluation of continuous glucose monitoring systems. Led by Prof. Dr. Andreas Pfützner, the organization also conducts significant research into cardiovascular biomarkers and diagnostic tools for metabolic syndrome. Their facilities are equipped to handle complex metabolic research, making them a key partner for global biotech and medtech companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pfützner Science.